Agile Therapeutics appoints Scott Coiante as SVP, CFO; CAO Jason Butch to depart

AGILE THERAPEUTICS INC

Scott Coiante appointed SVP, CFO and Treasurer effective Aug 16, 2023; he previously served as Agile's CFO from 2010-2019.
Jason Butch to separate as Chief Accounting Officer on Aug 15, 2023 by mutual agreement.
Butch to receive 6 months base salary and health care subsidies as severance, subject to signing release.
Coiante most recently CFO of Aprea Therapeutics; prior roles at Medarex and Ernst & Young.
No family relationships or material interests between Coiante and any director or officer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jason Butch

Chief Accounting Officer

AGILE THERAPEUTICS INC

Effective: 2023-08-15
Filed: June 27, 2023, 7:59 PM ET

the Company and Jason Butch came to a mutual agreement pursuant to which Mr. Butch will separate from service as the Chief Accounting Officer, effective August 15, 2023.

Appointed

Scott Coiante

Senior Vice President, Chief Financial Officer and Treasurer

AGILE THERAPEUTICS INC

Effective: 2023-08-16
Filed: June 27, 2023, 7:59 PM ET

the Board of Directors of Agile Therapeutics, Inc. (the “Company”) appointed Scott Coiante to serve as Senior Vice President. Chief Financial Officer and Treasurer, effective August 16, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Butch departed as Chief Accounting Officer at AGILE THERAPEUTICS INC.

Action: separate from service
Role: Chief Accounting Officer

Exact text from the filing

the Company and Jason Butch came to a mutual agreement pursuant to which Mr. Butch will separate from service as the Chief Accounting Officer, effective August 15, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott Coiante was appointed as Senior Vice President, Chief Financial Officer and Treasurer at AGILE THERAPEUTICS INC.

Action: appointed
Role: Senior Vice President, Chief Financial Officer and Treasurer

Exact text from the filing

the Board of Directors of Agile Therapeutics, Inc. (the “Company”) appointed Scott Coiante to serve as Senior Vice President. Chief Financial Officer and Treasurer, effective August 16, 2023.

View on SEC.gov

Source: SEC EDGAR

accession 0001558370-23-011461

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.